Gut Feelings: With Dr. D and GI Jo: A Rome Foundation/DrossmanCare Podcast Series

In this episode of Gut Feelings, Dr D and Johannah talk with registered dietitian Wendy Busse and discuss a condition she calls "conditioned food sensitivity" and the negative impacts it can have on patients with IBS and other GI illnesses. We also discuss the role of the GI dietitian in the overall management of patients with DGBI and clinical considerations prior to making a diet therapy recommendation.

See more about Wendy's FAST Freedom program to combat conditioned food sensitivity on her website: https://fastfreedomprogram.com/

As we prepare to launch our new book, Gut Feelings: The Patient's Story, we hear from one of our patients, Lesley who is featured in the book. We talk with her about her illness experience, how she found effective management and what she learned from the process. Its a fascinating and important conversation.

Dr Drossman discusses our recent study and publication on the aspects that drive patient satisfaction with care

In this episode, we hear from Dr. Drossman about the evolution of Functional GI and how we have shifted to a better understanding of these conditions and the role of the brain-gut axis.

On this episode, Dr. A and Johannah talk with Dr. Helen Burton Murray about Avoidance Restrictive Feeding DIsorder (AFRID) and Rumination Disorder, both conditions getting more common in patients with digestive illnesses. Dr. Murray talks about the diagnosis of them and treatments, as well as screening for ARFID in adult and pediatric patients.

Today we are joined by Dr Anthony Lembo and Dr. Sarah Ballou, from Beth Israel Deaconess Medical Center and Harvard Medical School to discuss this fascinating topic of research that is being done with patients with chronic pain conditions and with disorders of gut-brain interaction. What is the placebo effect and the nocebo effect and how can it actually benefit patients with these conditions? What role does the brain-gut connection have in this phenomenon?

Today Doug and Johannah review the types of drug that are now referred to as neuromodulators and share a patient scenario where a physician makes the recommendation for their use but finds a reluctant patient. How do you effectively communicate the rationale and benefits to a patient?